Sign In

Julia Schoelermann

Biotech Business Development & Corporate Comms executive - passionate about translating science into medicines|PhD, MBA

Professional Background

Julia Schoelermann is a distinguished leader in the fields of biotechnology and early drug development, dedicated to creating long-term value and sustainable growth in her industry. With extensive international experience and a depth of cross-functional knowledge, Julia has honed her expertise in various aspects of business development, oncology, public relations, and investor relations. As of now, she serves as the Director of Business Development & Investor Relations at Forbius, where she utilizes her rich background in life sciences to drive innovative solutions forward in her organization.

Prior to her current role, Julia held influential positions at BerGenBio ASA, a leading biotech company focused on developing and commercializing novel cancer therapies. During her time there, she progressed through various roles, including Associate Director of Business Development & Partnering and External Collaboration Manager, culminating in her position as Director of Business Development. Her tenure at BerGenBio not only demonstrates her commitment to advancing drug development but also showcases her capability in forming strategic partnerships that elevate organizational goals.

Education and Achievements

Julia Schoelermann has an impressive educational background that greatly enhances her professional expertise. She received her Master of Business Administration (MBA) from the prestigious IE Brown Executive MBA program, a joint initiative between Brown University and IE Business School, reflecting her deep commitment to merging technical knowledge and business acumen. Her educational journey also includes a Doctor of Philosophy (PhD) in Cell Biology from the University of Bergen (UiB), where she developed a robust foundation in scientific research and methodology.

In addition to her degrees, Julia has pursued further qualifications, including a Certificate in Board Competence from BI Norwegian Business School, underscoring her commitment to understanding governance and strategic oversight within organizations. Furthermore, her Bachelor’s and Master’s degrees in Molecular Biotechnology and Biophysical Chemistry from Ruprecht-Karls-Universität Heidelberg afford her a comprehensive understanding of the intricate biotechnological processes essential for effective drug development.

Achievement-oriented, Julia has not only excelled in her roles but also contributed to the academic community. She has served as a PhD and MSc supervisor at the University of Bergen and has successfully managed various research projects during her career, ensuring the next generation of scientists receives the guidance and support required to thrive.

Notable Contributions and Skills

Julia Schoelermann's work is characterized by a strong commitment to mentorship, cross-functional leadership, and strategic entrepreneurship. Her forward-thinking approach positions her as a vital asset in the business development landscape of biotechnology. Her specializations in oncology and early-stage pharma greatly influence her performance, allowing her to manage complex projects effectively, while her expertise in public and investor relations facilitates connections that are crucial for innovation and growth.

She expertly bridges the gap between scientific discovery and business strategy, driving initiatives that align with both organizational objectives and groundbreaking research, ultimately aiming for solutions that improve patient outcomes. With her keen problem-solving abilities and adeptness in communication, Julia effectively communicates complex scientific concepts clearly to diverse stakeholders, ranging from investors to regulatory bodies.

Conclusion

Driven by passion and expertise, Julia Schoelermann stands out as a leader dedicated to pioneering advances in biotech and early drug development. Her impressive academic background and noteworthy professional achievements illustrate her relentless pursuit to create value in her field, embodying the essence of innovation and leadership.

title

Related Questions

How did Julia Schoelermann develop her expertise in biotechnology and early drug development?
What leadership strategies does Julia Schoelermann employ to drive business growth in the biotech sector?
What are some notable partnerships Julia Schoelermann has fostered during her time at Forbius?
How has Julia Schoelermann's education influenced her career in the biotechnology field?
What role does mentorship play in Julia Schoelermann's professional philosophy?
Julia Schoelermann
Add to my network

Location

Austin, Texas, United States